Gene variants in pro-coagulant and anti-coagulant genes could be prognostic genetic markers of COVID-19 susceptibility
Open Access
- 11 November 2022
- Vol. 8 (11) , e11536
Abstract
No abstract availableKeywords
Funding Information
- Defence Research and Development Organisation
This publication has 30 references indexed in Scilit:
- Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, ItalyThrombosis Research, 2020
- Epidemiology of COVID-19 Among Children in ChinaPediatrics, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Gender Differences in Patients With COVID-19: Focus on Severity and MortalityFrontiers in Public Health, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Lack of Rule-Adherence During Mountain Gorilla Tourism Encounters in Bwindi Impenetrable National Park, Uganda, Places Gorillas at Risk From Human DiseaseFrontiers in Public Health, 2020
- MetaGenyo: a web tool for meta-analysis of genetic association studiesBMC Bioinformatics, 2017